Home › Urinary Incontinence › NCT06369922

TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.

Transcutaneous Electrical Nerve Stimulation Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* • Women, Age ≥18 years

  * Diagnosis of SUI
  * Scheduled to undergo transurethral bulking in the office
  * Able to read/write English

Exclusion Criteria:

* • Cutaneous damage such as ulcers or broken skin on target treatment area

  * Currently implanted cardiac pacemaker or defibrillator
  * Pre-procedural use of opioids for pain management, less than 8 hours from last dose
  * Participants with altered sensation below the umbilicus

About the study

This will be a double-blind randomized control trial in women with stress urinary incontinence who are undergoing an outpatient transurethral bulking procedure for stress urinary incontinence. Subjects will be identified by the University of Rochester urologists and urogynecologists participating in the study who currently oversee stress incontinence care. Subjects will be randomized into two groups. One group will be undergoing the cystoscopy with transcutaneous electrical nerve stimulation (TENS) for analgesia, and the second group will have the cystoscopy with placebo TENS.

What is being tested

• TENS (procedure)
• Control TENS (procedure)

Sponsor: University of Rochester · Participants: 100 · Started: Jul 1, 2024

Contact the study team

• Jared M Floch, DO, MS · Phone: 585-895-9301
• Diego Hernandez-Aranda, MD · Phone: 585-487-3400

Official record on ClinicalTrials.gov — NCT06369922

Locations in the U.S.

Conditions

• Urinary Incontinence
• Pelvic Floor Disorders
• Pain
• Acute Pain

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.